What are the goals of pharmacotherapy for hemolytic anemia?

Updated: May 27, 2021
  • Author: Srikanth Nagalla, MD, MS, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The goals of pharmacotherapy are to reduce morbidity and to prevent complications in patients with hemolytic anemia. Treatment is specific to the type of hemolytic anemia. For example, corticosteroids are usually the first line of treatment in autoimmune hemolytic anemia (AIHA) but are seldom effective in pediatric cold agglutinin disease. Rituximab has been used and can be effective in steroid-resistant AIHA. [45, 60]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!